Literature DB >> 19661615

Extracellular amyloid-beta and cytotoxic glial activation induce significant entorhinal neuron loss in young PS1(M146L)/APP(751SL) mice.

Ines Moreno-Gonzalez1, David Baglietto-Vargas, Raquel Sanchez-Varo, Sebastian Jimenez, Laura Trujillo-Estrada, Elisabeth Sanchez-Mejias, Juan Carlos Del Rio, Manuel Torres, Manuel Romero-Acebal, Diego Ruano, Marisa Vizuete, Javier Vitorica, Antonia Gutierrez.   

Abstract

Here we demonstrated that extracellular, not intracellular, amyloid-beta (Abeta) and the associated cytotoxic glial neuroinflammatory response are major contributors to early neuronal loss in a PS1xAPP model. A significant loss of principal (27%) and SOM/NPY (56-46%) neurons was found in the entorhinal cortex at 6 months of age. Loss of principal cells occurred selectively in deep layers (primarily layer V) whereas SOM/NPY cell loss was evenly distributed along the cortical column. Neither layer V pyramidal neurons nor SOM/NPY interneurons displayed intracellular Abeta immunoreactivity, even after formic acid retrieval; thus, extracellular factors should be preferentially implicated in this selective neurodegeneration. Amyloid deposits were mainly concentrated in deep layers at 4-6 months, and of relevance was the existence of a potentially cytotoxic inflammatory response (TNFalpha, TRAIL, and iNOS mRNAs were upregulated). Moreover, non-plaque associated activated microglial cells and reactive astrocytes expressed TNFalpha and iNOS, respectively. At this age, in the hippocampus of same animals, extracellular Abeta induced a non-cytotoxic glial activation. The opposite glial activation, at the same chronological age, in entorhinal cortex and hippocampus strongly support different mechanisms of disease progression in these two regions highly affected by Abeta pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661615     DOI: 10.3233/JAD-2009-1192

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  16 in total

1.  Alzheimer's disease and epilepsy: insight from animal models.

Authors:  Helen E Scharfman
Journal:  Future Neurol       Date:  2012-03-01

2.  Impaired Peripheral Lymphatic Function and Cerebrospinal Fluid Outflow in a Mouse Model of Alzheimer's Disease.

Authors:  Sunkuk Kwon; Ines Moreno-Gonzalez; Kathleen Taylor-Presse; George Edwards Iii; Nazaret Gamez; Olivia Calderon; Banghe Zhu; Fred Christian Velasquez; Claudio Soto; Eva M Sevick-Muraca
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  Parvalbumin-Positive Neuron Loss and Amyloid-β Deposits in the Frontal Cortex of Alzheimer's Disease-Related Mice.

Authors:  Farhan Ali; Stephanie L Baringer; Arianna Neal; Esther Y Choi; Alex C Kwan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 4.  Targeting the Cation-Chloride Co-Transporter NKCC1 to Re-Establish GABAergic Inhibition and an Appropriate Excitatory/Inhibitory Balance in Selective Neuronal Circuits: A Novel Approach for the Treatment of Alzheimer's Disease.

Authors:  Simona Capsoni; Ivan Arisi; Francesca Malerba; Mara D'Onofrio; Antonino Cattaneo; Enrico Cherubini
Journal:  Brain Sci       Date:  2022-06-15

5.  Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus.

Authors:  Raquel Sanchez-Varo; Laura Trujillo-Estrada; Elisabeth Sanchez-Mejias; Manuel Torres; David Baglietto-Vargas; Ines Moreno-Gonzalez; Vanessa De Castro; Sebastian Jimenez; Diego Ruano; Marisa Vizuete; Jose Carlos Davila; Jose Manuel Garcia-Verdugo; Antonio Jesus Jimenez; Javier Vitorica; Antonia Gutierrez
Journal:  Acta Neuropathol       Date:  2011-10-22       Impact factor: 17.088

6.  In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.

Authors:  Laura Trujillo-Estrada; Sebastian Jimenez; Vanessa De Castro; Manuel Torres; David Baglietto-Vargas; Ines Moreno-Gonzalez; Victoria Navarro; Raquel Sanchez-Varo; Elisabeth Sanchez-Mejias; Jose Carlos Davila; Marisa Vizuete; Antonia Gutierrez; Javier Vitorica
Journal:  Acta Neuropathol Commun       Date:  2013-11-12       Impact factor: 7.801

7.  Amyloid-β reduces the expression of neuronal FAIM-L, thereby shifting the inflammatory response mediated by TNFα from neuronal protection to death.

Authors:  P Carriba; S Jimenez; V Navarro; I Moreno-Gonzalez; B Barneda-Zahonero; R S Moubarak; J Lopez-Soriano; A Gutierrez; J Vitorica; J X Comella
Journal:  Cell Death Dis       Date:  2015-02-12       Impact factor: 8.469

8.  Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus.

Authors:  Manuel Torres; Sebastian Jimenez; Raquel Sanchez-Varo; Victoria Navarro; Laura Trujillo-Estrada; Elisabeth Sanchez-Mejias; Irene Carmona; Jose Carlos Davila; Marisa Vizuete; Antonia Gutierrez; Javier Vitorica
Journal:  Mol Neurodegener       Date:  2012-11-22       Impact factor: 14.195

9.  Dual roles of Aβ in proliferative processes in an amyloidogenic model of Alzheimer's disease.

Authors:  David Baglietto-Vargas; Elisabeth Sánchez-Mejias; Victoria Navarro; Sebastián Jimenez; Laura Trujillo-Estrada; Angela Gómez-Arboledas; Maria Sánchez-Mico; Raquel Sánchez-Varo; Marisa Vizuete; José Carlos Dávila; José Manuel García-Verdugo; Javier Vitorica; Antonia Gutierrez
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

10.  Microglia in Alzheimer's Disease: Activated, Dysfunctional or Degenerative.

Authors:  Victoria Navarro; Elisabeth Sanchez-Mejias; Sebastian Jimenez; Clara Muñoz-Castro; Raquel Sanchez-Varo; Jose C Davila; Marisa Vizuete; Antonia Gutierrez; Javier Vitorica
Journal:  Front Aging Neurosci       Date:  2018-05-11       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.